![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 39, 27407-27414, September 24, 1999
From the Institut für Pharmakologie und Toxikologie
der Albert-Ludwigs-Universität Freiburg, Hermann-Herder-Strasse
5, D-79104 Freiburg, Germany
Clostridium botulinum exoenzyme C3
inactivates the small GTPase Rho by ADP-ribosylation. We used a C3
fusion toxin (C2IN-C3) with high cell accessibility to study the
kinetics of Rho inactivation by ADP-ribosylation. In primary cultures
of rat astroglial cells and Chinese hamster ovary cells, C2IN-C3
induced the complete ADP-ribosylation of RhoA and concomitantly the
disassembly of stress fibers within 3 h. Removal of C2IN-C3 from
the medium caused the recovery of stress fibers and normal cell
morphology within 4 h. The regeneration was preceded by the
appearance of non-ADP-ribosylated RhoA. Recovery of cell morphology was
blocked by the proteasome inhibitor lactacystin and by the translation
inhibitors cycloheximide and puromycin, indicating that intracellular
degradation of the C3 fusion toxin and the neosynthesis of Rho were
required for reversal of cell morphology. Escherichia coli
cytotoxic necrotizing factor CNF1, which activates Rho by deamidation
of Gln63, caused reconstitution of stress fibers and cell
morphology in C2IN-C3-treated cells within 30-60 min. The effect of
CNF1 was independent of RhoA neosynthesis and occurred in the presence of completely ADP-ribosylated RhoA. The data show three novel findings;
1) the cytopathic effects of ADP-ribosylation of Rho are rapidly
reversed by neosynthesis of Rho, 2) CNF1-induced deamidation activates
ADP-ribosylated Rho, and 3) inhibition of Rho activation but not
inhibition of Rho-effector interaction is a major mechanism underlying
inhibition of cellular functions of Rho by ADP-ribosylation.
This article has been cited by other articles:
![]() |
H. Barth, K. Aktories, M. R. Popoff, and B. G. Stiles Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins Microbiol. Mol. Biol. Rev., September 1, 2004; 68(3): 373 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Essler, S. Linder, B. Schell, K. Hufner, A. Wiedemann, K. Randhahn, J. M. Staddon, and M. Aepfelbacher Cytotoxic Necrotizing Factor 1 of Escherichia coli Stimulates Rho/Rho-Kinase-Dependent Myosin Light-Chain Phosphorylation without Inactivating Myosin Light-Chain Phosphatase in Endothelial Cells Infect. Immun., September 1, 2003; 71(9): 5188 - 5193. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Genth, R. Gerhard, A. Maeda, M. Amano, K. Kaibuchi, K. Aktories, and I. Just Entrapment of Rho ADP-ribosylated by Clostridium botulinum C3 Exoenzyme in the Rho-Guanine Nucleotide Dissociation Inhibitor-1 Complex J. Biol. Chem., August 1, 2003; 278(31): 28523 - 28527. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Hopkins, S. V. Walsh, P. Verkade, P. Boquet, and A. Nusrat Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function J. Cell Sci., February 15, 2003; 116(4): 725 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lerm, M. Pop, G. Fritz, K. Aktories, and G. Schmidt Proteasomal Degradation of Cytotoxic Necrotizing Factor 1-Activated Rac Infect. Immun., August 1, 2002; 70(8): 4053 - 4058. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Carton, D. Trouet, D. Hermans, H. Barth, K. Aktories, G. Droogmans, N. K. Jorgensen, E. K. Hoffmann, B. Nilius, and J. Eggermont RhoA exerts a permissive effect on volume-regulated anion channels in vascular endothelial cells Am J Physiol Cell Physiol, July 1, 2002; 283(1): C115 - C125. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Leemhuis, S. Boutillier, G. Schmidt, and D. K. Meyer The Protein Kinase A Inhibitor H89 Acts on Cell Morphology by Inhibiting Rho Kinase J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 1000 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Nougayrede, M. Boury, C. Tasca, O. Marches, A. Milon, E. Oswald, and J. De Rycke Type III Secretion-Dependent Cell Cycle Block Caused in HeLa Cells by Enteropathogenic Escherichia coli O103 Infect. Immun., November 1, 2001; 69(11): 6785 - 6795. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gulke, G. Pfeifer, J. Liese, M. Fritz, F. Hofmann, K. Aktories, and H. Barth Characterization of the Enzymatic Component of the ADP-Ribosyltransferase Toxin CDTa from Clostridium difficile Infect. Immun., October 1, 2001; 69(10): 6004 - 6011. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Budnik and A. K. Mukhopadhyay Lysophosphatidic Acid Antagonizes the Morphoregulatory Effects of the Luteinizing Hormone on Luteal Cells: Possible Role of Small Rho-G-Proteins Biol Reprod, July 1, 2001; 65(1): 180 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wahl, H. Barth, T. Ciossek, K. Aktories, and B. K. Mueller Ephrin-A5 Induces Collapse of Growth Cones by Activating Rho and Rho Kinase J. Cell Biol., April 17, 2000; 149(2): 263 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wilde, G. S. Chhatwal, G. Schmalzing, K. Aktories, and I. Just A Novel C3-like ADP-ribosyltransferase from Staphylococcus aureus Modifying RhoE and Rnd3 J. Biol. Chem., March 16, 2001; 276(12): 9537 - 9542. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Rodriguez-Fernandez, L. Sanchez-Martin, M. Rey, M. Vicente-Manzanares, S. Narumiya, J. Teixido, F. Sanchez-Madrid, and C. Cabanas Rho and Rho-associated Kinase Modulate the Tyrosine Kinase PYK2 in T-cells through Regulation of the Activity of the Integrin LFA-1 J. Biol. Chem., October 26, 2001; 276(44): 40518 - 40527. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |